These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20387006)

  • 21. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: Role of insufficient hydrogen sulfide.
    Cheng Z; Shen X; Jiang X; Shan H; Cimini M; Fang P; Ji Y; Park JY; Drosatos K; Yang X; Kevil CG; Kishore R; Wang H
    Redox Biol; 2018 Jun; 16():215-225. PubMed ID: 29524844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.
    Weiss N
    Curr Drug Metab; 2005 Feb; 6(1):27-36. PubMed ID: 15720205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the cystathionine-gamma-lyase/hydrogen sulfide pathway in rat vascular smooth muscle cells by cobalt-60 gamma radiation.
    Zhong GZ; Yang XC; Jia LP; Chen FR; Cui M
    Chin Med J (Engl); 2009 Feb; 122(3):326-30. PubMed ID: 19236813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalance of Homocysteine and H
    Yang Q; He GW
    Oxid Med Cell Longev; 2019; 2019():7629673. PubMed ID: 31885816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis.
    García-Tevijano ER; Berasain C; Rodríguez JA; Corrales FJ; Arias R; Martín-Duce A; Caballería J; Mato JM; Avila MA
    Hypertension; 2001 Nov; 38(5):1217-21. PubMed ID: 11711526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hydrogen sulfide as a biologically active mediator in the cardiovascular system].
    Bełtowski J
    Postepy Hig Med Dosw (Online); 2004 Jul; 58():285-91. PubMed ID: 15280798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbed homocysteine metabolism is associated with cancer.
    Hasan T; Arora R; Bansal AK; Bhattacharya R; Sharma GS; Singh LR
    Exp Mol Med; 2019 Feb; 51(2):1-13. PubMed ID: 30804341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2.
    Welch GN; Upchurch GR; Farivar RS; Pigazzi A; Vu K; Brecher P; Keaney JF; Loscalzo J
    Proc Assoc Am Physicians; 1998; 110(1):22-31. PubMed ID: 9460080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.
    Vacek TP; Rehman S; Neamtu D; Yu S; Givimani S; Tyagi SC
    Vasc Health Risk Manag; 2015; 11():173-83. PubMed ID: 25767394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new strategy to treat hyperhomocysteinemia].
    Geng B; Chang L; Du JB; Tang CS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):215-9. PubMed ID: 15841160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
    Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of vascular disease in hyperhomocysteinaemia.
    Domagała TB; Undas A; Libura M; Szczeklik A
    J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
    Tsuda K; Nishio I
    Circulation; 2004 Jul; 110(4):e37. PubMed ID: 15277339
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia.
    Tyagi N; Moshal KS; Ovechkin AV; Rodriguez W; Steed M; Henderson B; Roberts AM; Joshua IG; Tyagi SC
    J Cell Biochem; 2005 Nov; 96(4):665-71. PubMed ID: 16149054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.